Early diagnosis pathway for laboratory testing in the context of pertussis resurgence

百日咳疫情复燃背景下的实验室检测早期诊断路径

阅读:1

Abstract

The resurgence of pertussis continues to be a global public health concern, especially in China in recent years. It is critical to identify atypical cases in adolescents and adults and to improve sensitivity to early laboratory diagnosis. The subjects were laboratory-confirmed cases in Chaoyang district between 2018 and 2023, detected through pertussis symptom surveillance, or reported in the National Notifiable Disease Reporting System. Logistic regression and decision tree models were used to examine potential factors influencing laboratory diagnostic sensitivity. Among the 446 laboratory-confirmed cases, the sensitivity of PCR and serological diagnosis of single serums was 83.4% and 49.5%. Logistic regression analysis showed that age and vaccination, disease course at sampling, and years of onset were the factors that affected the sensitivity of laboratory diagnosis (p < .05). The decision tree model indicated that the sensitivity of PCR was highest among unvaccinated and partially vaccinated cases (97.9%), while it was lowest in adults (63.3%); PCR sensitivity in children and adolescents vaccinated with 3-4 doses was 79.1%, and the sensitivity increases to 88.4% at sampling during the first 3 weeks of onset. Serodiagnostic sensitivity was low, especially in unvaccinated cases (4.5%), and higher in adults, children and adolescents receiving booster immunization (63.1%), but decreased to 46.2% at sampling during the first 3 weeks of onset. Because serological diagnostic sensitivity is low and overlaps in positivity with PCR is limited (9.2%), lower cut-off values are recommended to improve diagnostic sensitivity in the early stages of the disease, in adults, in children and adolescents receiving booster immunization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。